# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 108: Amendment to regulation 251

Extent: E+W+S+N.I.

In regulation 251(7) (compliance with standards specified in certain publications: definition of “relevant marketing authorisation”)—
(a) omit sub-paragraph (a);
(b) in sub-paragraph (c), for “UKMA(GB)” substitute “UKMA(UK)(Category 2)”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/108 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-108
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.